UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial

Journal of clinical oncology, 2010-01, Vol.28 (3), p.466-474

2010

Volltextzugriff (PDF)

Irinotecan Plus Gemcitabine Results in No Survival Advantage Compared With Gemcitabine Monotherapy in Patients With Locally Advanced or Metastatic Pancreatic Cancer Despite Increased Tumor Response Rate

Journal of clinical oncology, 2004-09, Vol.22 (18), p.3776-3783

2004

Volltextzugriff (PDF)

Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3

Journal of clinical oncology, 2009-07, Vol.27 (19), p.3117-3125

2009

Volltextzugriff (PDF)

Real-World Treatment Patterns and Costs for Patients with Renal Cell Carcinoma Initiating Treatment with Sunitinib and Pazopanib

Journal of managed care & specialty pharmacy, 2016-08, Vol.22 (8), p.979-990

2016

Volltextzugriff (PDF)

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Journal of clinical oncology, 2012-03, Vol.30 (7), p.709-717

2012

Volltextzugriff (PDF)

Real-world chart review study of adverse events management in patients taking tyrosine kinase inhibitors to treat metastatic renal cell carcinoma

Journal of oncology pharmacy practice, 2018-12, Vol.24 (8), p.574-583

2018

Volltextzugriff (PDF)

Long-term Duration of First-Line Axitinib Treatment in Advanced Renal Cell Carcinoma

Targeted oncology, 2017-06, Vol.12 (3), p.333-340

2017

Volltextzugriff (PDF)

Phase II Trial of Irinotecan in Children With Relapsed or Refractory Rhabdomyosarcoma: A Joint Study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group

Journal of clinical oncology, 2007-02, Vol.25 (4), p.356-361

2007

Volltextzugriff (PDF)

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

JNCI : Journal of the National Cancer Institute, 2012-11, Vol.104 (21), p.1635-1646

2012

Volltextzugriff (PDF)

Phase 1 and Pharmacokinetic Study of Intravenous Irinotecan in Refractory Solid Tumor Patients with Hepatic Dysfunction

Clinical cancer research, 2006-06, Vol.12 (12), p.3782-3791

2006

Volltextzugriff (PDF)

Treatment patterns and costs associated with axitinib and everolimus treatment for renal cell carcinoma: A retrospective health claims analysis

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e16089-e16089

2016

Volltextzugriff (PDF)

Real-World Axitinib Use in the United States: A Retrospective Study Using Linked Datasets

Journal of managed care & specialty pharmacy, 2016-06, Vol.22 (6), p.723-732u

2016

Volltextzugriff (PDF)

Axitinib treatment among patients with mRCC in a U.S. community oncology setting: A retrospective study of 135 patients

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.569-569

2016

Volltextzugriff (PDF)

Utility of Pretreatment Bilirubin Level and UGT1A1 Polymorphisms in Multivariate Predictive Models of Neutropenia Associated with Irinotecan Treatment in Previously Untreated Patients with Colorectal Cancer

Archives of drug information, 2008-12, Vol.1 (3), p.97-106

2008

Volltextzugriff (PDF)

Sunitinib and pazopanib treatment patterns and cost outcomes in Medicare supplemental-covered patients with renal cell carcinoma

Journal of clinical oncology, 2015-03, Vol.33 (7_suppl), p.485-485

2015

Volltextzugriff (PDF)

Axitinib in metastatic renal cell carcinoma: patient characteristics and treatment patterns in US community oncology centers

Future oncology (London, England), 2017-06, Vol.13 (15), p.1323-1332

2017

Volltextzugriff (PDF)

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

Neuro-oncology (Charlottesville, Va.), 2013-09, Vol.15 (9), p.1236-1243

2013

Volltextzugriff (PDF)

Phase I Clinical and Pharmacologic Trial of Intravenous Estramustine Phosphate

Journal of clinical oncology, 2002-02, Vol.20 (4), p.1115-1127

Hudes, G.

2002

Volltextzugriff (PDF)

Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial

Targeted oncology, 2015-03, Vol.10 (1), p.45-53

2015

Volltextzugriff (PDF)

Effect of niacin supplementation on fibrinogen levels in patients with peripheral vascular disease

The American journal of cardiology, 1998-09, Vol.82 (5), p.697-699

1998

Volltextzugriff (PDF)

A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: A European cooperation of the Société Française d’Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)

European journal of cancer (1990), 2008-11, Vol.44 (16), p.2453-2460

2008

Volltextzugriff (PDF)

A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study

Journal of neuro-oncology, 2013-05, Vol.113 (1), p.127-134

2013

Volltextzugriff (PDF)

The complete nucleotide sequence of cell fusing agent (CFA): Homology between the nonstructural proteins encoded by CFA and the nonstructural proteins encoded by arthropod-borne flaviviruses

Virology (New York, N.Y.), 1992-08, Vol.189 (2), p.511-524

1992

Volltextzugriff (PDF)

Association of hemostatic factors with peripheral vascular disease

The American heart journal, 1997-11, Vol.134 (5), p.978-984

1997

Volltextzugriff (PDF)

Phase I clinical and pharmacologic trial of intravenous estramustine phosphate

Journal of clinical oncology, 2002-02, Vol.20 (4), p.1115-1127

2002

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(34)
Dissertationen
(1)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Science & Technology
(27)
Humans
(24)
Female
(21)
Male
(20)
Biological And Medical Sciences
(18)
Middle Aged
(17)
Oncology
(16)
Aged
(14)
Medical Sciences
(12)
Adult
(11)
Camptothecin - Administration & Dosage
(8)
Camptothecin - Analogs & Derivatives
(8)
Adolescent
(7)
Treatment Outcome
(7)
Tumors
(7)
Fundamental And Applied Biological Sciences. Psychology
(6)
Aged, 80 And Over
(5)
Antineoplastic Agents - Therapeutic Use
(5)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial

Irinotecan Plus Gemcitabine Results in No Survival Advantage Compared With Gemcitabine Monotherapy in Patients With Locally Advanced or Metastatic Pancreatic Cancer Despite Increased Tumor Response Rate

Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3

Real-World Treatment Patterns and Costs for Patients with Renal Cell Carcinoma Initiating Treatment with Sunitinib and Pazopanib

Disease-Related Outcomes With Long-Term Follow-Up: An Updated Analysis of the Intergroup Exemestane Study

Real-world chart review study of adverse events management in patients taking tyrosine kinase inhibitors to treat metastatic renal cell carcinoma

Long-term Duration of First-Line Axitinib Treatment in Advanced Renal Cell Carcinoma

Phase II Trial of Irinotecan in Children With Relapsed or Refractory Rhabdomyosarcoma: A Joint Study of the French Society of Pediatric Oncology and the United Kingdom Children's Cancer Study Group

Integrated Analysis of Molecular and Clinical Prognostic Factors in Stage II/III Colon Cancer

Phase 1 and Pharmacokinetic Study of Intravenous Irinotecan in Refractory Solid Tumor Patients with Hepatic Dysfunction

Treatment patterns and costs associated with axitinib and everolimus treatment for renal cell carcinoma: A retrospective health claims analysis

Real-World Axitinib Use in the United States: A Retrospective Study Using Linked Datasets

Axitinib treatment among patients with mRCC in a U.S. community oncology setting: A retrospective study of 135 patients

Utility of Pretreatment Bilirubin Level and UGT1A1 Polymorphisms in Multivariate Predictive Models of Neutropenia Associated with Irinotecan Treatment in Previously Untreated Patients with Colorectal Cancer

Sunitinib and pazopanib treatment patterns and cost outcomes in Medicare supplemental-covered patients with renal cell carcinoma

Axitinib in metastatic renal cell carcinoma: patient characteristics and treatment patterns in US community oncology centers

Phase II study of irinotecan in combination with temozolomide (TEMIRI) in children with recurrent or refractory medulloblastoma: a joint ITCC and SIOPE brain tumor study

Phase I Clinical and Pharmacologic Trial of Intravenous Estramustine Phosphate

Hypertension among patients with renal cell carcinoma receiving axitinib or sorafenib: analysis from the randomized phase III AXIS trial

Effect of niacin supplementation on fibrinogen levels in patients with peripheral vascular disease

A phase II study of irinotecan in children with relapsed or refractory neuroblastoma: A European cooperation of the Société Française d’Oncologie Pédiatrique (SFOP) and the United Kingdom Children Cancer Study Group (UKCCSG)

A phase II single-arm study of irinotecan in combination with temozolomide (TEMIRI) in children with newly diagnosed high grade glioma: a joint ITCC and SIOPE-brain tumour study

The complete nucleotide sequence of cell fusing agent (CFA): Homology between the nonstructural proteins encoded by CFA and the nonstructural proteins encoded by arthropod-borne flaviviruses

Association of hemostatic factors with peripheral vascular disease

Phase I clinical and pharmacologic trial of intravenous estramustine phosphate

Suchergebnisse filtern